Franklin Genomic Advancements

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HELX and other ETFs, options, and stocks.

About HELX

HELX is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. The listed name for HELX is Franklin Genomic Advancements ETF. 

Index-Tracked
Index-Tracked
Category
Health
CategoryHealth
Number of holdings
68
Number of holdings68
Inception Date
Feb 25, 2020
Inception DateFeb 25, 2020

What's in this fund

Sectors

As of December 3, 2025
Healthcare97.38%
Basic Materials1.86%
Technology0.76%

HELX Key Statistics

AUM
22.63M
AUM22.63M
Price-Earnings ratio
-621.26
Price-Earnings ratio-621.26
30-Day yield
30-Day yield
Average volume
2.79K
Average volume2.79K
High today
$37.65
High today$37.65
Low today
$37.27
Low today$37.27
Open price
$37.65
Open price$37.65
Volume
2.25K
Volume2.25K
52 Week high
$38.11
52 Week high$38.11
52 Week low
$23.74
52 Week low$23.74
Expense ratio
0.50
Expense ratio0.50

Stock Snapshot

Franklin Genomic Advancements(HELX) stock is priced at $37.21, giving the company a market capitalization of 22.33M. It carries a P/E multiple of -621.26 and pays a dividend yield of 11.3%.

On 2025-12-06, Franklin Genomic Advancements(HELX) stock traded between a low of $37.27 and a high of $37.65. Shares are currently priced at $37.21, which is -0.1% above the low and -1.2% below the high.

The Franklin Genomic Advancements(HELX)'s current trading volume is 2.25K, compared to an average daily volume of 2.79K.

During the past year, Franklin Genomic Advancements(HELX) stock moved between $23.74 at its lowest and $38.11 at its peak.

During the past year, Franklin Genomic Advancements(HELX) stock moved between $23.74 at its lowest and $38.11 at its peak.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.